The −283C/T polymorphism of the DNMT3B gene influences the progression of joint destruction in rheumatoid arthritis
- 118 Downloads
The objective of this study is to investigate the association between the −283C/T polymorphism at the promotor of DNMT3B gene and susceptibility to rheumatoid arthritis (RA) and to evaluate the effect of the polymorphism on clinical features such as progression of joint destruction in RA. A total of 309 patients with RA were compared with 297 control subjects. Genotyping of the −283C/T polymorphism was performed by real-time sequencing using Pyrosequencer. The genotype frequencies of the polymorphism at position −283 were not significantly different between patients with RA and controls. There were significantly positive correlations between the modified Sharp score and the disease duration for carriers of each genotype (y = 9.546x + 19.998, p < 0.001, for T allele carriers, y = 6.185x + 34.424, p < 0.001 for CC homozygotes). The slope of regression line of the T allele carriers was significantly steeper than that of the CC homozygotes (p = 0.014). In conclusion, our results suggest that the −283C/T polymorphism of the DNMT3B gene is a genetic marker related to the joint destruction of RA.
KeywordsDNMT3B Polymorphism Rheumatoid arthritis Modified Sharp score
This work was supported by a Medical Research Institute grant, Kyungpook National University Hospital (2005).
Conflict of interest statement
The authors declare that they have no conflict of interest.
- 5.Quddus J, Johnson KJ, Gavalchin J et al (1993) Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest 92:38–53. doi: 10.1172/JCI116576 CrossRefPubMedGoogle Scholar
- 17.Mikovits JA, Young HA, Vertino P et al (1998) Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production. Mol Cell Biol 18:5166–5177PubMedGoogle Scholar